Insulin resistance, microalbuminuria, and chronic kidney disease Pantelis A. SarafidisLuis M. Ruilope Invited Commentary 30 October 2008 Pages: 249 - 251
ADVANCE in management of vascular complications of diabetes Helmy M. Siragy Clinical Trials Report 30 October 2008 Pages: 255 - 257
A new mandate for treating hypertension in the elderly Michael A. Weber Clinical Trials Report 30 October 2008 Pages: 258 - 260
Evidence for benefits of angiotensin receptor blockade beyond blood pressure control Helmy M. Siragy OriginalPaper 30 October 2008 Pages: 261 - 267
Dopamine receptors and hypertension Anees Ahmad BandayMustafa F. Lokhandwala OriginalPaper 30 October 2008 Pages: 268 - 275
Do ACE inhibitors all provide the same outcomes benefits in high-risk cardiovascular patients? Anu LalaMary Ann McLaughlin OriginalPaper 30 October 2008 Pages: 286 - 292
Should chlorthalidone be the diuretic of choice for antihypertensive therapy? Sandra J. Taler OriginalPaper 30 October 2008 Pages: 293 - 297
Treating very elderly hypertensive patients is rewarding: The HYVET results Giuseppe ManciaGuido Grassi Clinical Trials Report 30 October 2008 Pages: 301 - 302
ONTARGET for hypertension or not? Thomas D. Giles Clinical Trials Report 30 October 2008 Pages: 303 - 304
Advances in the understanding of eclampsia S. Ananth KarumanchiMarshall D. Lindheimer OriginalPaper 30 October 2008 Pages: 305 - 312
Direct renin inhibition: An analysis of possible benefits Brian K. DockeryJohn D. Bisognano OriginalPaper 30 October 2008 Pages: 313 - 318
Insulin resistance and blood pressure Sonya AddisonSameer StasJames R. Sowers OriginalPaper 30 October 2008 Pages: 319 - 325
Treating prehypertension: A review of the evidence Norman M. Kaplan OriginalPaper 30 October 2008 Pages: 326 - 329
Pharmacologic considerations in the positioning of β-blockers in antihypertensive therapy Domenic A. SicaHenry R. Black OriginalPaper 30 October 2008 Pages: 330 - 335